baber/WOPTO huggingface dataset:
Patent DK-2771955-T3 (DK)
Inventor: ZHU HUIBIN
IPC: G01R31/50
Filed: 2011-10-28
Granted: 2018-01-22
Abstract: Systems (100), power modules (108), and methods for using in controlling a converter (110) coupled between a power generator (104) and an electric grid (102). A power module (108) includes the converter (110) configured to supply the output from the power generator (104) to the electric grid (102) and a controller (112) coupled to the converter (110) and configured to disable the converter (110) in response to a grid fault event, to identify the type or the grid fault event after a first predetermined interval from disabling the converter (110), and to enable switching of the converter (110), when the type of the grid fault event is identified as a low voltage condition.
Patent DK-2802338-T3 (DK)
Inventor: MOGELSVANG SOREN
IPC: C07K14/81
Filed: 2013-01-07
Granted: 2018-06-14
Abstract: We describe peptides and their uses for the treatment of autoimmune, inflammatory and metabolic diseases.
Patent DK-0391039-T3 (DK)
Inventor: HOTTINGER HERBERT
IPC: C12Q1/68
Filed: 1990-02-10
Granted: 1994-10-31
Abstract: The DNA probe comprises a DNA fragment capable of hybridisation to chromosomal DNA of strains of the L.delbrueckii species. This DNA fragment comprises an EcoRI fragment of chromosomal DNA from a strain of the L.delbrueckii species.
Patent DK-0386595-T3 (DK)
Inventor: PAWELZIK MANFRED
IPC: E03C1/042
Filed: 1990-02-27
Granted: 1994-09-05
Abstract: In a mixing valve, having at least two connections (arranged at a distance from one another) for the hot and cold water supply and having a valve body in which in each case there is provided a shut-off valve for the cold and hot water or a mixing and shut-off valve as well as at least one outlet opening for the mixed water, in order to improve production and the versatility of use of the mixing valve it is proposed that the valve body consist of a mixer part having at least one outlet opening, to which two tubular pieces can be connected diagonally opposite one another in a detachable manner, in each case at least one connection arranged at right angles to the tube axis being provided on the tubular pieces for the supply lines. 
<IMAGE>
Patent DK-0415766-T3 (DK)
Inventor: MEZICK JAMES A
IPC: A61P17/00
Filed: 1990-08-30
Granted: 1997-01-27
Abstract: The present invention is directed to the topical administration of a retinoid-containing pharmaceutical composition for reversing the effects of glucocorticoid-induced skin atrophy.
Patent DK-0460043-T3 (DK)
Inventor: SHEPHERD DONALD WELTON
IPC: B62H1/06
Filed: 1990-02-26
Granted: 1994-11-07
Abstract: PCT No. PCT/GB90/00296 Sec. 371 Date Jul. 11, 1991 Sec. 102(e) Date Jul. 11, 1991 PCT Filed Feb. 26, 1990 PCT Pub. No. WO90/09918 PCT Pub. Date Sep. 7, 1990.A stabiliser system, primarily for supporting a pedal bicycle and its rider upright at the halt, comprises a spring-loaded telescopic arm (25) pivoted at its upper end adjacent the rear wheel spindle (12) and having at its lower end a cross-shaft (26) carrying stabiliser wheels (27). The arm can be lowered by back-pedalling to draw a cable (22) onto a spool (31) on the pedal spindle (18). The cross-shaft also carries a flanged roller (51). When the arm is lowered by back-pedalling as the rider comes to a halt, the cross-shaft (26) is drawn beneath the rear wheel and the tire (13) is engaged by the roller and the rear wheel is lifted off the ground, a large part of the weight of the rider being transferred to the ground through the rear wheel, the roller, the cross-shaft and the stabiliser wheels.
Patent DK-0454801-T3 (DK)
Inventor: MCGRAW PHILIP W
IPC: C10M107/38
Filed: 1990-10-11
Granted: 1994-10-24
Abstract: Refrigeration fluid compositions for compression refrigeration which have an upper solution critical temperature equal to or greater than about 35 DEG  C. are composed of selected hydrochlorofluorocarbons and hydrofluorocarbons with esterified polyether polyols in which at least 30% of the hydroxyls are esterified. The esterified polyether polyols have a viscosity between 25 and 150 centistokes at 38 DEG  C.
Patent DK-0463338-T3 (DK)
Inventor: LOOS HORST
IPC: E05D5/14
Filed: 1991-05-10
Granted: 1994-02-21
Abstract: A plastic moulding 1 is provided for connection or coupling to a metal moulding, sleeve-shaped at least in regions, especially for the simultaneous encasing and lining of pivot sockets for hinges or the like. It is characterised in that a one-piece, thin-walled injection moulding consists of a casing portion 2 of a spacial form adapted to the outer contour of the metal moulding, and of at least one tubular core portion 3a or 3b adjoining it coaxially as an extension and of a spacial form matched to the inner contour of the metal moulding, in that the core portion 3a or 3b adjoins a transverse end wall 2a or 2b of the casing portion 2, and in that in the transitional region 27 between each end or transverse wall 2a or 2b and the core portion 3a or 3b an approximately annularly extending predetermined breaking point 5a or 5b is provided around the outer circumference of the core portion 3a or 3b. This affords a connection or coupling of the plastic moulding to the metal moulding, which can be made easily at any time, but which then guarantees a permanently effective retention on the metal moulding. <IMAGE>
Patent DK-0504290-T3 (DK)
Inventor: SANTI DANIEL V
IPC: A61K31/53
Filed: 1990-12-07
Granted: 1997-08-11
Abstract: A method for inhibiting growth of Pneumocystis carinii in a mammalian host, which comprises administering to the host an amount of a 1-phenyl-s-triazine effective to inhibit growth of P. carinii. Preferred compounds have formula (I), wherein X, Y, and Z are independently selected from preferred organic substituents described in the specification; R1 is lower alkyl; and R2 is hydrogen or methyl; as well as compounds formed by reaction of an organic or inorganic acid with a triazine of this formula to form an amide or acid addition salt. Administration of precursors which form the triazine in vivo is also within the scope of the invention.
Patent DK-0504291-T3 (DK)
Inventor: LINSLEY PETER S
IPC: C12N15/00
Filed: 1990-12-07
Granted: 1998-11-30
Abstract: The present invention is directed to biologically mutant forms of the cell growth regulatory factor Oncostatin M. The Oncostatin M mutants of the invention comprise deletion, substitution and insertion mutants and may be prepared using recombinant DNA, in vitro mutagenesis and heterologous expression techniques. Oncostatin M mutants may be useful in eliciting Oncostatin M biological responses and, as such, may find a variety of therapeutic uses including but not limited to the treatment of neoplasias.
Patent DK-0506790-T3 (DK)
Inventor: STARNES ROBERT L
IPC: C12P19/18
Filed: 1990-12-21
Granted: 1994-03-21
Abstract: A method for enzymatically converting solid and liquefied starch into cyclodextrins using cyclodextrin glycosyl transferases (CGTase) elaborated by thermophilic obligate anaerobic strains belonging to the genus Clostridium. These CGTases are characterized by thermostability and a capability to liquefy starch and/or to convert liquefied starch to cyclodextrins at pH 5.0-5.5 and 60-90  DEG C.
Patent DK-0583743-T3 (DK)
Inventor: HERTENSTEIN ULRICH DR
IPC: C07C69/82
Filed: 1993-08-12
Granted: 1997-06-09
Abstract: The invention relates to a novel process for the preparation of terephthalic diesters and diols from polyesters. The process comprises depolymerization of the polyester in the presence of transesterification catalysts for said polyester and in the presence of an ester and subsequent transesterification of the reaction mixture to give the terephthalic diester by reaction with a monohydric alcohol. The novel process allows the starting components of polyesters to be recovered rapidly and under mild reaction conditions.
Patent DK-0652163-T3 (DK)
Inventor: POSTLER WOLFGANG
IPC: B65D21/02
Filed: 1993-11-04
Granted: 1999-06-14
Abstract: A dual container for multiple-component products, in particular two-component adhesives, comprising a container (1) with a receiving lid (2) having an undercut (7), and a plug-on container (3) which is provided at its lower fold edge (4, 5) with a bead engaging behind the undercut, and in which the surface of the receiving lid (2) is fitted with a peripheral groove (6), and the groove (6) is fitted at its upper inner edge with a projecting outer bead (8) having an outside diameter corresponding to the inside diameter of the fold edge (4) of the plug-on container (3), and the bottom fold (5) being set inwards, calibrated to an extent which is less than the extent of the outer bead (8). <IMAGE>
Patent DK-0603650-T3 (DK)
Inventor: KLEEMANN HEINZ-WERNER DR
IPC: A61P9/00
Filed: 1993-12-08
Granted: 1997-10-20
Abstract: Benzoylguanidines of the formula I <IMAGE>  having one of the substituents R(1), R(2), R(3) or R(4):  an amino group <IMAGE> where R(5) and R(6) are, inter alia, H or alkyl, or R(5) and R(6), together with the N atom, are a 5-7-membered ring, and the other substituents R(1), R(2), R(3) and R(4) are in each case: H, Hal, CN, CF3, NO2, CF3-O-, CmF2m+1-CH2-O- or R(11)-CqH2q -Xp-, X is O or NR(12) and R(11) is H, (cyclo)alkyl or phenyl, with R(1) and R(4) not being hydrogen simultaneously,  are described. The compounds I possess very good anti-arrhythmic and cardio-protective properties but do not have any undesirable salidiuretic properties. In addition, they exhibit protective properties against ischaemically-induced damage in vivo and in vitro in various organs, and also gastroprotective properties as a result of inhibiting gastric acid secretion. In addition to this, they are notable for their inhibitory effect on the proliferation of cells.
Patent DK-0618905-T3 (DK)
Inventor: SHIH NENG-YANG
IPC: C07D233/88
Filed: 1992-12-16
Granted: 1995-12-04
Abstract: Disclosed is a compound of formula (1.0) or a pharmaceutically acceptable salt or solvate thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an effective amount of a compound of formula (1.0). Further disclosed is a method of treating allergy (for example asthma), inflammation, hypertension, raised intraocular pressure (such as glaucoma) - i.e., a method of lowering intraocular pressure, sleeping disorders, states of hyper and hypo motility and acidic secretion of the gastrointestinal tract, hypo and hyperactivity of the central nervous system (for example, agitation and depression) and other CNS disorders (such as Alzheimers, Schizophrenia, and migraine) comprising administering an effective amount of a compound of Formula (I) to a patient in need of such treatment.
Patent DK-0639963-T3 (DK)
Inventor: EVANS JOHN CHRISTOPHER
IPC: A61F13/00
Filed: 1993-05-10
Granted: 1998-03-30
Abstract: PCT No. PCT/GB93/00958 Sec. 371 Date Nov. 7, 1994 Sec. 102(e) Date Nov. 7, 1994 PCT Filed May 10, 1993 PCT Pub. No. WO93/22994 PCT Pub. Date Nov. 25, 1993There is described a woven bandage which exhibits a crepe effect and which contains composite warp yarns (1) and weft filaments (7) wherein the composite warp yarns (1) are formed by twisting a staple fiber yarn (2) and a textured filament yarn (3) together. The staple fiber yarn (2) forms loops (4) which gives the bandage a crepe effect. There is also described a process for the manufacture of such woven bandages and an article of manufacture which includes the composite warp yarns used in the woven bandage.
Patent DK-0639150-T3 (DK)
Inventor: BOOTH IAN ANTHONY
IPC: B65D90/02
Filed: 1993-04-29
Granted: 1996-01-29
Abstract: PCT No. PCT/GB93/00893 Sec. 371 Date Dec. 12, 1994 Sec. 102(e) Date Dec. 12, 1994 PCT Filed Apr. 29, 1993 PCT Pub. No. WO93/22223 PCT Pub. Date Nov. 11, 1993An aircraft cargo container adapted to provide blast attenuation in the event of an explosion within the container comprises panels (2,3) of blast resistant material joined together by joint means (4,5) which are adapted to provide a relatively rigid joint udner normal handling conditions, but which provide a relatively flexible hinged joint capable of transmitting tensile loads between the panels under blast conditions. Additional reinforcement may be provided by a lattice of high tensile strength straps 6 substantially surrounding the container.
Patent DK-0643716-T3 (DK)
Inventor: EBETINO FRANK H
IPC: A61P3/00
Filed: 1993-05-27
Granted: 2000-03-27
Abstract: The present invention relates to a quaternary nitrogen-containing, saturated or unsaturated monocyclic and bicyclic ring containing phosphonate and the pharmaceutically-acceptable salts and esters thereof, having structure (I). The present invention further relates to pharmaceutical compositions containing a safe and effective amount of a compound of the present invention, and pharmaceutically-acceptable excipients. Finally, the present invention relates to methods for treating or preventing pathological conditions characterized by abnormal calcium and phosphate metabolism in humans or other mammals. This method comprises administering to a human or other mammal in need of such treatment of a safe and effective amount of a compound or composition of the present invention.
Patent DK-0579828-T3 (DK)
Inventor: GEORG EDGAR
IPC: B65F3/04
Filed: 1993-02-08
Granted: 1999-03-22
Abstract: The refuse containers (24) are picked up by the lifting arms (23) from in front of the vehicle and are lifted over the cab roof to tip into the collecting bin. The support frame for the lift and tilt arms is mounted on the chassis behind the cab and extends over the roof of the cab to the pivot points at the front top edge of the cab. The arms are hydraulically powered. The lift control holds the container upright until it reaches the tipping position. The double joined lift arms are controlled to keep the height to a min. over the cab. The containers are tipped into a collecting hopper (10) from where the refuse is pressed into the main part of the vehicle.
Patent DK-0647654-T3 (DK)
Inventor: JONES CHARLES DAVID
IPC: C07H19/06
Filed: 1994-09-12
Granted: 2000-03-13
Abstract: Anomeric 2,2-difluororibosyl azide and amine intermediates which are useful in the preparation of 2'-deoxynucleosides, and processes thereto.
Patent DK-0626385-T3 (DK)
Inventor: BULUSU A R C MURTY
IPC: A61K31/407
Filed: 1994-05-24
Granted: 2004-02-16
Abstract: The invention concerns the compounds of formula I <CHEM> wherein the substituents have various significances, in free form and, where such forms exist, in salt form. They can be prepared by various processes, e.g. by irradiation; oxidation; elimination; reduction; conversion by e.g. halogenation or acylation; deprotection of protected hydroxy groups; protection of free hydroxy groups; and separation of stereoisomeric mixtures into individual isomers. They are indicated for use as pharmaceuticals, especially as antiinflammatory, and as antiproliferative and antiinflammatory agents.
Patent DK-0725715-T3 (DK)
Inventor: MIKO HANS-JUERGEN
IPC: B28B1/42
Filed: 1994-04-28
Granted: 1998-03-23
Abstract: The invention relates to processes and installations for the manufacture of products consisting of fibres and hydraulic binder in which, in the process, a mixture of a fibre phase and a binder phase is produced and said mixture is applied in the pneumatic conveying process on an air-permeable circulating conveyor belt (3) to form a layer (4) and in which, during its time on the conveyor belt, the layer is subjected to a densification and moistening cycle (5). The main feature of the process of the invention is that the mixture is processed into a moist mass before its transfer to the conveyor belt (3) and said moist mass is scattered directly on the moving conveyor belt (3) by means of the pneumatic conveying process to form a layer (4), it is densified during its movement on the conveyor belt (3) downstream of the scattering region, additional water (8) in at least the quantity needed for making the product is applied to said layer after or during its densification and, after the addition of the extra water, said layer is wound in several layers on a winding or format roller (9).
Patent DK-0709094-T3 (DK)
Inventor: BODICK NEIL C
IPC: A61K31/439
Filed: 1995-10-30
Granted: 2000-07-10
Abstract: The present invention provides the use of a compound <CHEM>  wherein  Z1 is oxygen or sulphur; R is hydrogen, halogen, amino, -NHCO-R<2>, C3-7-cycloalkyl, C4-10-(cycloalkylalkyl), -Z<2>-C3-7-cycloalkyl optionally substituted with C1-6-alkyl, -Z<2>-C4-10-(cycloalkylalkyl), -Z<2>-C4-10-(cycloalkenylalkyl), -Z<2>-C4-10-(methylenecycloalkyl-alkyl), -NH-R2, -NR2R3, -NH-OR2, phenyl, phenoxy, benzoyl, benzyloxycarbonyl, tetrahydronaphtyl, indenyl, X, R<2>, -Z<2>R<2>, -SOR<2>, -SO2R<2>, -Z<2>-R<2>-Z<3>-R<3>, -Z<2>-R<2>-Z<3>-R<3>-Z<4>-R<4>, -Z<2>-R<2>CO-R<3>, -Z<2>-R<2>-CO2-R<3>, Z<2>-R<2>-O2C-R<3>, -Z<2>-R<2>-CONH-R<3>, -Z<2>-R<2>-NHCOR<3>, -Z<2>-R<2>-X, -Z<2>-R<2>-Z<3>-X, wherein Z<2>, Z<3>, and Z<4> independently are oxygen or sulphur, and R<2>, R<3> and R<4> independently are straight or branched C1-15-alkyl, straight or branched C2-15-alkenyl, straight or branched C2-15-alkynyl, each of which is optionally substituted with halogen(s), -OH, -CN, -CF3, -SH, -COOH, -NH-R<2>, -NR<2>R<3>, C1-6alkyl ester, one or two phenyl, phenoxy, benzoyl or benzyloxycarbonyl wherein each aromatic group is optionally substituted with one or two halogen, -CN, C1-4-alkyl or C1-4-alkoxy, and X is a 5 or 6 membered heterocyclic group containing one to four N, O or S atom(s) or a combination thereof, which heterocyclic group is optionally substituted at carbon or nitrogen atom(s) with straight or branched C1-6-alkyl, phenyl, benzyl or pyridine, or a carbon atom in the heterocyclic group together with an oxygen atom form a carbonyl group, or which heterocyclic group is optionally fused with a phenyl group; and R<5> and R<6> may be present at any position, including the point of attachment of the thiadiazole or oxadiazole ring, and independently are hydrogen, straight or branched C1-5-alkyl, straight or branched C2-5-alkenyl, straight or branched C2-5-alkynyl, straight or branched C1-10-alkoxy, straight or branched C1-5-alkyl substituted with -OH, -OH, halogen, -NH2 or carboxy; R<1> is hydrogen, straight or branched C1-5-alkyl, straight or branched C2-5-alkenyl or straight or branched C2-5-alkynyl; or a pharmaceutically acceptable salt or solvate thereof; for the manufacture of a medicament for the treatment of anxiety.
Patent DK-0715856-T3 (DK)
Inventor: KAMISHITA TAKUZO
IPC: A61K9/06
Filed: 1995-04-19
Granted: 2007-12-10
Abstract: A keratin-storable antifungal composition for external use, which contains an antifungal with a high keratin affinity as the active ingredient and also contains at least one liquid oily substance selected from among methyl salicylate, glycol salicylate, crotamiton, mentha oil and methol, and wherein the antifungal has an enhnaced capability of penetrating into kerating and is improved in the restorability therein.
Patent DK-0813597-T3 (DK)
Inventor: JOSIC DJURO
IPC: B01J20/32
Filed: 1996-02-10
Granted: 2007-02-05
Abstract: A process for the purification of vitamin K dependent coagulation factors by affinity chromatography wherein fractions of a source containing said vitamin K dependent factors are a) subjected to chromatography on a material modified with 2-hydroxyaminopropyl groups bonded to spacers having more than 3 carbon atoms, said source being applied from a solution whose ionic strength is chosen such that said vitamin K dependent coagulation factors are adsorbed on the above anion-exchange material, washing is optionally performed with an appropriate buffer solution, then, after separation of the eluate, b) a buffer solution of higher ionic strength than that used in step a) is contacted with the affinity chromatographic material such that said vitamin K dependent factors are eluted, then this fraction is either processed further to give a PPSB preparation, or these fractions containing the factors are pooled and then said fractions c) are subjected to a second chromatographic step in the form of a heparin affinity chromatography.
Patent DK-0827411-T3 (DK)
Inventor: WAHL RICHARD L
IPC: A61N5/00
Filed: 1996-05-03
Granted: 2005-10-24
Abstract: A method for determining the number of millicurie to be administered to a patient so as to deliver a given centigray (cGy) dose of either the patient's lean body of the patient's total body. The method includes the steps of injecting a radioactive tracer into a patient, determining radiation levels in the whole body, calculating a geometric mean based on the radiation levels, determining the percent-injected activity remaining in the body at each time point, plotting the percent-injected activity versus calculated time from infusion on a log-linear graph, determining the effective half-life and the rate of clearance from the log-linear graph, cross-indexing the effective half-life vlue with the patient's body weight, and multiplying the determined amount of therapeutic millicurie per centigray by the amount of desired centigray to be administered.
Patent DK-0824599-T3 (DK)
Inventor: GOH SWEE HAN
IPC: C12N15/09
Filed: 1996-04-26
Granted: 2006-05-22
Abstract: The present invention provides oligonucleotide primers and a method of using these primers for identification of the species of an organism, wherein the identification includes amplification of a variable polynucleotide sequence encoding a highly conserved region of a heat shock polypeptide.
Patent DK-0833626-T3 (DK)
Inventor: ROSINI SERGIO
IPC: A61K31/18
Filed: 1996-06-17
Granted: 2003-06-30
Abstract: PCT No. PCT/EP96/02597 Sec. 371 Date Jan. 29, 1998 Sec. 102(e) Date Jan. 29, 1998 PCT Filed Jun. 17, 1996 PCT Pub. No. WO97/00675 PCT Pub. Date Jan. 9, 1997Compounds of formula (I) for treatment of pathologies in which erosion of cartilaginous and bone matrix occurs, for example osteoarthrosis. An exampliary compound is 2,6-anthraquinonesulfonamido-N,N-caproic acid.    <IMAGE>  (I)
Patent DK-0955491-T3 (DK)
Inventor: ROUSSEL JEAN
IPC: F16K15/14
Filed: 1997-12-31
Granted: 2001-01-29
Abstract: The valve, which is intended to regulate the passage of a fluid through an orifice in a wall  
 comprises a tubular body and a flexible rubber cover which deforms under the action of the pressures [(P1 and P2)] prevailing in the spaces on each side of the valve.
Patent DK-0912341-T3 (DK)
Inventor: VALENTE GABRIELE
IPC: B32B27/06
Filed: 1997-06-10
Granted: 2003-07-21
Abstract: A supporting material in the form of sheet or roll, constituted of a cellulosic material, or a rolled section in paper treated with a solution, or a rolled section in melaminic paper, or a mixture of leather regenerated materials or derivatives thereof, or cardboard or cardboard fiber, or needled fabrics, or synthetic or natural rubber, or foam made of reticulated polyethylene with closed cells, or foam made of reticulated polyethylene with closed celle, or natural or synthetic leather, or non-woven fabric, neoprene, masonite, recycled polyethylene, nylon, Lilion3, Tyvec3, polyester or a net made of synthetic material, or cork or wood, or a coagulated material, or felt, or foamed polyurethane, foamed polyethylene, foamed polystyrene, or a perspiring material, or an agglomerated stone-like material, is coupled to a covering layer made of polyethylene or Surlyn3, whereby the upper surface of the covering layer is embossed, in such a way as to imitate another material. This composite material has a high surface resistance, thus being particularly suitable for a plurality of applications; furthermore, said composite material is non-toxic and thus usable for contacting the skin for a long period of time.                               00000